Psyence Biomedical Ltd.
PBMNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.30M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.92$21.75
- Volume (live)
- -
- Avg. volume (3M)
- 73.80K
Psyence Biomedical (PBM) Stock Price & Financial Analysis
Psyence Biomedical Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.06 - $4.29 |
|---|---|
| 52-Week High | $21.75 |
| 52-Week Low | $1.92 |
| Open | $4.11 |
| Volume (last close) | 13.17K |
| Average Volume (3M) | 73.80K |
| 50-Day MA | $4.83 |
|---|---|
| 200-Day MA | $4.03 |
| 1-Year Change | −80.23% |
| Market Cap | 2.30M |
|---|---|
| Shares Outstanding | 552.28K |
| Price to Book (P/B) | 0.14 |
| EV/EBITDA | 0.90 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Psyence Biomedical at a Glance
As of the Oct 23, 2026 close, Psyence Biomedical (PBM) has a market capitalization of $2.30M.
As of its latest reported balance sheet, it holds $7.44M in cash and securities against $0.00 of debt, a net cash position of $7.44M.
Psyence Biomedical does not currently pay a dividend.
The share price is down 80.2% over the past year. At $4.17 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.92 to $21.75, above its 200-day moving average of $4.03.
Frequently Asked Questions About Psyence Biomedical
What is the current stock price for PBM?
As of the Oct 23, 2026 close, PBM stock trades at $4.17. The 52-week range is $1.92–$21.75, with a day range of $4.06–$4.29.
What is the P/E ratio for PBM?
The P/E ratio (Price-to-Earnings) for PBM is shown in the Key Statistics section. This valuation metric helps compare Psyence Biomedical Ltd. to industry peers.
Does PBM pay dividends?
Psyence Biomedical does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PBM?
Analyst ratings and recommendations for PBM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PBM?
As of the Oct 23, 2026 close, Psyence Biomedical's market capitalization is $2.3M, classifying it as a micro-cap company. Psyence Biomedical operates in the Healthcare sector within the Biotechnology industry.